Showing results (141-150 of 168) with videos related to
Sort By:
Pageof 17
Mabs|February 9, 2016
Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of actionJames C Geoghegan, Gundo Diedrich, Xiaojun Lu, et al.Leukemia & Lymphoma|July 28, 2016
Treatment of Early Stage Hodgkin's Disease According to Risk FactorsT Chisesi, M Vespignani, G Capnist, et al.The Journal of Biological Chemistry|September 12, 2014
Mechanisms of neutralization of a human anti-α-toxin antibodyVaheh Oganesyan, Li Peng, Melissa M Damschroder, et al.Mabs|April 7, 2016
A novel antibody discovery platform identifies anti-influenza A broadly neutralizing antibodies from human memory B cellsXiaodong Xiao, Yan Chen, Reena Varkey, et al.Mabs|May 14, 2015
Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) bindingM Jack Borrok, Nadia M Luheshi, Nurten Beyaz, et al.Protein Engineering, Design & Selection : PEDS|February 13, 2019
Tag-on-Demand: exploiting amber codon suppression technology for the enrichment of high-expressing membrane protein cell linesZachary T Britton, Timothy B London, Jeffrey Carrell, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequencesWilliam F Dall'Acqua, Robert M Woods, E Sally Ward, et al.ACS Chemical Biology|March 11, 2020
Engineering Caveolae-Targeted Lipid Nanoparticles To Deliver mRNA to the LungsQing Li, Chingshen Chan, Norman Peterson, et al.Acta Crystallographica. Section D, Biological Crystallography|November 4, 2015
Structural insights into the interaction of human IgG1 with FcγRI: no direct role of glycans in bindingVaheh Oganesyan, Yariv Mazor, Chunning Yang, et al.Pageof 17